Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Miki Takenaka
Feasibility Study of Personalized Peptide Vaccination for Metastatic Recurrent Triple-Negative Breast Cancer Patients
Breast Cancer Research
Cancer Research
Oncology
Related publications
Phase II and Biomarker Study of Cabozantinib in Metastatic Triple‐Negative Breast Cancer Patients
Oncologist
Cancer Research
Medicine
Oncology
Biology, Metastatic Patterns, and Treatment of Patients With Triple-Negative Breast Cancer
Clinical Cancer Reviews
Nab-Paclitaxel for the Management of Triple-Negative Metastatic Breast Cancer
Anti-Cancer Drugs
Cancer Research
Oncology
Pharmacology
Feasibility Study of Personalized Peptide Vaccination for Advanced Non-Small Cell Lung Cancer Patients Who Failed Two or More Treatment Regimens
International Journal of Oncology
Cancer Research
Oncology
Triple-Negative Breast Cancer
Recurrent CYP2C19 Deletion Allele Is Associated With Triple-Negative Breast Cancer
BMC Cancer
Cancer Research
Oncology
Genetics
Immediate and Long-Term Outcomes of Drug Treatment in Patients With Metastatic Triple Negative Breast Cancer
Malignant tumours
The Results of a Study of Chemotherapy With Bevacizumab, Oxaliplatin and Paclitaxel in Patients With Metastatic Triple Negative Breast Cancer
Malignant tumours
Phase II Study of Pembrolizumab and Capecitabine for Triple Negative and Hormone Receptor-Positive, HER2−negative Endocrine-Refractory Metastatic Breast Cancer
Journal for ImmunoTherapy of Cancer
Oncology
Molecular Medicine
Pharmacology
Cancer Research
Allergy
Immunology
